1. Home
  2. Companies
  3. Invivoscribe
IN

Invivoscribe

About

Invivoscribe is a global leader in precision oncology diagnostics, dedicated to improving lives with standardized molecular testing solutions. For over 30 years, the company has pioneered the international standardization of molecular and flow cytometry testing, expanding access to advanced cancer therapies worldwide. Invivoscribe develops and manufactures a comprehensive portfolio of molecular assays, reagents, controls, and bioinformatics tools under ISO 13485 design control, supporting more than 700 clinical laboratories in over 160 countries.

The company's Streamlined CDx (companion diagnostic) model accelerates the development of novel therapeutics, enabling personalized approaches to patient care. Invivoscribe's products consistently surpass industry and regulatory standards, playing a crucial role in identifying, stratifying, and monitoring hematologic cancers. Through its subsidiary, the Laboratory for Personalized Molecular Medicine (LabPMM), Invivoscribe offers extensive clinical diagnostic and biopharma services, providing globally standardized flow cytometry and molecular testing services for pharmaceutical and healthcare organizations across the U.S., Europe, and Asia.

Similar companies

LS

Lumiere Systems Inc

IT Software Services / Solutions

5 jobs
II

Illumina, Inc.

Illumina is improving human health by unlocking the power of the genome. The company provides sequencing and array technologies that fuel genomic discoveries, enabling life-changing breakthroughs in cancer research, reproductive health, genetic disease understanding, and translational and consumer genomics. As a global genomics leader, Illumina innovates to make genomics more accessible to researchers, clinicians, and patients worldwide. Founded in 1998 and headquartered in San Diego, California, Illumina develops integrated systems for the analysis of genetic variation and function. The company's comprehensive portfolio spans high-throughput sequencing platforms like NovaSeq X and NextSeq systems, microarray scanners, library preparation kits, and informatics solutions including BaseSpace Sequence Hub and DRAGEN. By empowering researchers and clinicians with tools that improve cancer treatments, change disease trajectories, and protect future generations, Illumina is transforming the future of precision health and making genomics useful for all.

1 job
ZM

ZOLL Medical Corporation

ZOLL Medical Corporation, an Asahi Kasei company, develops and markets medical devices and software solutions that advance emergency care and save lives while increasing clinical and operational efficiencies. Named after Dr. Paul M. Zoll, a pioneer in cardiac pacing and defibrillation, the company has built a comprehensive portfolio spanning defibrillation, cardiac monitoring, circulation enhancement, CPR feedback, ventilation, therapeutic temperature management, and sleep apnea diagnosis. ZOLL serves first responders, hospitals, military personnel, and lay rescuers worldwide with technologies designed to improve patient outcomes in the most critical moments. With products for emergency care, critical care, and cardiac patient management, ZOLL provides innovative solutions including automated external defibrillators, wearable defibrillators, automated CPR devices, monitors/defibrillators, ventilators, and data management software. The company's mission is rooted in its founding commitment to resuscitation science, offering solutions that empower clinicians and responders to deliver better care when lives are on the line. ZOLL's portfolio includes the LifeVest Wearable Cardioverter Defibrillator, Heart Failure Management System, and WatchPAT Sleep Apnea Solutions.

1 job
EM

Enterra Medical

At Enterra Medical, we believe in restoring more than just physical symptoms - we believe in giving people their lives back. Our team is singularly focused on helping patients with chronic gastroparesis find relief through the Enterra® Therapy system, a groundbreaking gastric electrical stimulation approach. We were founded in 2022 with a specific mission: to advance technology, expand clinical science, and accelerate access to this life-changing therapy. With over 15,000 patients already treated, we know our work makes a tangible difference in people's daily lives. Our culture is defined by relentless dedication to patient outcomes and scientific rigor. Originally developed by Medtronic and FDA-approved in 2000, Enterra Therapy is now in the hands of a team that lives and breathes gastroparesis treatment. We collaborate closely with healthcare providers, from implanting surgeons to referring gastroenterologists, ensuring every patient receives comprehensive support throughout their journey. Our engineers and medical professionals work together to continuously improve our implantable neurostimulation technology, which delivers mild electrical pulses to reduce nausea and vomiting. We are not just manufacturing devices - we are providing hope for patients who have exhausted other treatment options.

CG

Cboe Global Markets

Cboe Global Markets is the world's leading exchange network for derivatives, securities, and digital asset trading solutions. Founded in 1973 as the Chicago Board Options Exchange, Cboe pioneered the first listed options contract in the United States, fundamentally transforming the financial landscape. Today, the company operates a robust portfolio of exchanges across North America, Europe, and Asia-Pacific, offering access to options, futures, cash equities, and foreign exchange markets. Cboe is renowned for creating and maintaining the VIX® Index, the global benchmark for market volatility, which has become an essential tool for investors worldwide. The company's cutting-edge technology powers markets globally through its unified trading platform, delivering real-time data, analytics, and clearing services to market participants. Cboe's commitment to innovation is evident in its continuous development of new products and solutions that help investors manage risk and achieve their financial objectives. With approximately 1,661 employees across offices in Chicago, New York, and international locations, Cboe combines deep market expertise with technological leadership. The company's purpose is to build trusted markets that provide a foundation of confidence, enabling investors to focus on managing risk and building sustainable financial futures.

PT

Proximate Technologies

We're Proximate Technologies, an IT services and consulting company that's been helping businesses transform their technical capabilities since 2006. Our team specializes in a wide range of services from software product engineering and digital transformation to cloud services, data science, and cybersecurity. We work across multiple industries including healthcare, telecommunications, e-commerce, and the public sector, bringing practical technical expertise to solve real business problems. What drives us is seeing our clients succeed - we align our approach with their business goals and deliver solutions that actually make a difference in their day-to-day operations. Our approach is straightforward: we combine technical expertise with a deep understanding of business needs. Whether we're developing custom mobile applications, implementing CRM solutions, building data analytics platforms, or providing talent acquisition services, we focus on delivering measurable results. We believe in being transparent about what works and what doesn't, and we're not afraid to tackle complex challenges head-on. Our team of certified professionals brings years of experience across various technologies, but what really sets us apart is how we work - we listen, we collaborate, and we make sure the solutions we build actually solve the problems our clients care about.